A citation-based method for searching scientific literature

Michelle Jacobson, Marcus Bernardini, Mara L Sobel, Raymond H Kim, Jeanna McCuaig, Lisa Allen. J Obstet Gynaecol Can 2018
Times Cited: 4







List of co-cited articles
17 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis.
C Marchetti, F De Felice, S Boccia, C Sassu, V Di Donato, G Perniola, I Palaia, M Monti, L Muzii, V Tombolini,[...]. Crit Rev Oncol Hematol 2018
28
75

Contemporary Hormonal Contraception and the Risk of Breast Cancer.
Lina S Mørch, Charlotte W Skovlund, Philip C Hannaford, Lisa Iversen, Shona Fielding, Øjvind Lidegaard. N Engl J Med 2017
162
75

Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
Sushmita Gordhandas, Barbara M Norquist, Kathryn P Pennington, Rachel L Yung, Mary B Laya, Elizabeth M Swisher. Gynecol Oncol 2019
35
75

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
50

Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
Laura Cortesi, Elisabetta De Matteis, Angela Toss, Isabella Marchi, Veronica Medici, Giannina Contu, Anjeza Xholli, Giovanni Grandi, Angelo Cagnacci, Massimo Federico. Oncology 2017
16
50


Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
491
50

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
Catherine A Shu, Malcolm C Pike, Anjali R Jotwani, Tara M Friebel, Robert A Soslow, Douglas A Levine, Katherine L Nathanson, Jason A Konner, Angela G Arnold, Faina Bogomolniy,[...]. JAMA Oncol 2016
115
50


Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
Elizabeth Hall, Amy Finch, Michelle Jacobson, Barry Rosen, Kelly Metcalfe, Ping Sun, Steven A Narod, Joanne Kotsopoulos. Gynecol Oncol 2019
20
50

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
731
50


Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.
Walter A Rocca, Brandon R Grossardt, Mariza de Andrade, George D Malkasian, L Joseph Melton. Lancet Oncol 2006
340
50

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2017
81
50

Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Joanne Kotsopoulos, Jacek Gronwald, Beth Y Karlan, Tomasz Huzarski, Nadine Tung, Pal Moller, Susan Armel, Henry T Lynch, Leigha Senter, Andrea Eisen,[...]. JAMA Oncol 2018
61
50

Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial.
JoAnn V Pinkerton, Jennifer A Harvey, Kaijie Pan, John R Thompson, Kelly A Ryan, Arkadi A Chines, Sebastian Mirkin. Obstet Gynecol 2013
81
50



Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
353
25


Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation.
Amy Finch, Adriana Valentini, Ellen Greenblatt, Henry T Lynch, Parviz Ghadirian, Susan Armel, Susan L Neuhausen, Charmaine Kim-Sing, Nadine Tung, Beth Karlan,[...]. Fertil Steril 2013
77
25

Low-dose aspirin use and the risk of ovarian cancer in Denmark.
L Baandrup, S K Kjaer, J H Olsen, C Dehlendorff, S Friis. Ann Oncol 2015
36
25

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
Marline G Harmsen, Marieke Arts-de Jong, Nicoline Hoogerbrugge, Angela H E M Maas, Judith B Prins, Johan Bulten, Steven Teerenstra, Eddy M M Adang, Jurgen M J Piek, Helena C van Doorn,[...]. BMC Cancer 2015
59
25

Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages.
Gretchen L Gierach, Ruth M Pfeiffer, Deesha A Patel, Amanda Black, Catherine Schairer, Abegail Gill, Louise A Brinton, Mark E Sherman. Menopause 2014
47
25


BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
227
25

Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study.
William H Parker, Diane Feskanich, Michael S Broder, Eunice Chang, Donna Shoupe, Cynthia M Farquhar, Jonathan S Berek, JoAnn E Manson. Obstet Gynecol 2013
258
25

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
R Manchanda, A Abdelraheim, M Johnson, A N Rosenthal, E Benjamin, C Brunell, M Burnell, L Side, S Gessler, E Saridogan,[...]. BJOG 2011
74
25

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
696
25

A comparison of live birth rates and perinatal outcomes between cryopreserved oocytes and cryopreserved embryos.
Jacqueline R Ho, Irene Woo, Kristin Louie, Wael Salem, Sami I Jabara, Kristin A Bendikson, Richard J Paulson, Karine Chung. J Assist Reprod Genet 2017
12
25

Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.
Adam H Buchanan, Corrine I Voils, Joellen M Schildkraut, Catherine Fine, Nora K Horick, P Kelly Marcom, Kristi Wiggins, Celette Sugg Skinner. J Genet Couns 2017
11
25

A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.
Rinat Yerushalmi, Shulamith Rizel, Dalia Zoref, Eran Sharon, Ram Eitan, Gad Sabah, Ahuva Grubstein, Yael Rafson, Maya Cohen, Ada Magen,[...]. Isr Med Assoc J 2016
7
25

Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer.
Joan L Walker, C Bethan Powell, Lee-May Chen, Jeanne Carter, Victoria L Bae Jump, Lynn P Parker, Mark E Borowsky, Randall K Gibb. Cancer 2015
141
25

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
128
25

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.
W A Rocca, J H Bower, D M Maraganore, J E Ahlskog, B R Grossardt, M de Andrade, L J Melton. Neurology 2007
460
25

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
25


The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
25

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
853
25

Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.
Patricia G Moorman, Laura J Havrilesky, Jennifer M Gierisch, Remy R Coeytaux, William J Lowery, Rachel Peragallo Urrutia, Michaela Dinan, Amanda J McBroom, Vic Hasselblad, Gillian D Sanders,[...]. J Clin Oncol 2013
116
25

Impact of surgical menopause on lipid and bone metabolism.
T Yoshida, K Takahashi, H Yamatani, K Takata, H Kurachi. Climacteric 2011
40
25

Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo. Cochrane Database Syst Rev 2018
34
25

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.
Mark E Sherman, Marion Piedmonte, Phuong L Mai, Olga B Ioffe, Brigitte M Ronnett, Linda Van Le, Iouri Ivanov, Maria C Bell, Stephanie V Blank, Paul DiSilvestro,[...]. J Clin Oncol 2014
78
25

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
C Bethan Powell, Eric Kenley, Lee-May Chen, Beth Crawford, Jane McLennan, Charles Zaloudek, Miriam Komaromy, Mary Beattie, John Ziegler. J Clin Oncol 2005
253
25

Persistence of fimbrial tissue on the ovarian surface after salpingectomy.
Carmen Gan, Rashna Chenoy, Dhivya Chandrasekaran, Elly Brockbank, Antony Hollingworth, Sotiris Vimplis, Alexandra C Lawrence, Arjun R Jeyarajah, David Oram, Nandita Deo,[...]. Am J Obstet Gynecol 2017
15
25

Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.
Laura J Havrilesky, Patricia G Moorman, William J Lowery, Jennifer M Gierisch, Remy R Coeytaux, Rachel Peragallo Urrutia, Michaela Dinan, Amanda J McBroom, Vic Hasselblad, Gillian D Sanders,[...]. Obstet Gynecol 2013
102
25

Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
A Benshushan, N Rojansky, M Chaviv, S Arbel-Alon, A Benmeir, T Imbar, A Brzezinski. Climacteric 2009
46
25

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
Britton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, Megan A Murphy, Ellen L Goode, Elizabeth M Poole, Louise A Brinton, Penelope M Webb, Christina M Nagle, Susan J Jordan,[...]. J Natl Cancer Inst 2014
134
25

Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study.
Thien Kieu Thi Phung, Berit Lindum Waltoft, Thomas Munk Laursen, Annette Settnes, Lars Vedel Kessing, Preben Bo Mortensen, Gunhild Waldemar. Dement Geriatr Cogn Disord 2010
103
25

BRCA1 germline mutations may be associated with reduced ovarian reserve.
Erica T Wang, Margareta D Pisarska, Catherine Bresee, Yii-Der Ida Chen, Jenny Lester, Yalda Afshar, Carolyn Alexander, Beth Y Karlan. Fertil Steril 2014
78
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.